EP3548036A4 - Natural combination hormone replacement formulations and therapies - Google Patents
Natural combination hormone replacement formulations and therapies Download PDFInfo
- Publication number
- EP3548036A4 EP3548036A4 EP17893482.4A EP17893482A EP3548036A4 EP 3548036 A4 EP3548036 A4 EP 3548036A4 EP 17893482 A EP17893482 A EP 17893482A EP 3548036 A4 EP3548036 A4 EP 3548036A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- therapies
- hormone replacement
- natural combination
- combination hormone
- replacement formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009472 formulation Methods 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662430339P | 2016-12-05 | 2016-12-05 | |
US201762481060P | 2017-04-03 | 2017-04-03 | |
PCT/US2017/064788 WO2018136161A1 (en) | 2016-12-05 | 2017-12-05 | Natural combination hormone replacement formulations and therapies |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3548036A1 EP3548036A1 (en) | 2019-10-09 |
EP3548036A4 true EP3548036A4 (en) | 2020-06-17 |
Family
ID=62908279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17893482.4A Withdrawn EP3548036A4 (en) | 2016-12-05 | 2018-02-02 | Natural combination hormone replacement formulations and therapies |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3548036A4 (en) |
JP (1) | JP2020504093A (en) |
KR (1) | KR20200018383A (en) |
CN (1) | CN110290793A (en) |
AU (1) | AU2017394679A1 (en) |
BR (1) | BR112019011655A2 (en) |
CA (1) | CA3045024A1 (en) |
IL (1) | IL267023A (en) |
MX (1) | MX2019006513A (en) |
RU (1) | RU2019115913A (en) |
WO (1) | WO2018136161A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220105107A1 (en) * | 2020-10-01 | 2022-04-07 | Michael Liguori | Bioidentical progesterone cream infused with nanoemulsified cbd |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
US6901278B1 (en) * | 2002-01-29 | 2005-05-31 | Morris Notelovitz | Methods for reducing the risk of breast cancer in and improving the health of women |
US20040062794A1 (en) * | 2002-09-30 | 2004-04-01 | Lee Shulman | 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy |
US9301920B2 (en) * | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
JP2017516768A (en) * | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | Natural combination hormone replacement therapy and therapy |
-
2017
- 2017-12-05 MX MX2019006513A patent/MX2019006513A/en unknown
- 2017-12-05 BR BR112019011655A patent/BR112019011655A2/en unknown
- 2017-12-05 AU AU2017394679A patent/AU2017394679A1/en active Pending
- 2017-12-05 RU RU2019115913A patent/RU2019115913A/en not_active Application Discontinuation
- 2017-12-05 JP JP2019530027A patent/JP2020504093A/en active Pending
- 2017-12-05 WO PCT/US2017/064788 patent/WO2018136161A1/en active Application Filing
- 2017-12-05 CA CA3045024A patent/CA3045024A1/en not_active Abandoned
- 2017-12-05 CN CN201780086119.7A patent/CN110290793A/en active Pending
-
2018
- 2018-02-02 EP EP17893482.4A patent/EP3548036A4/en not_active Withdrawn
- 2018-02-02 KR KR1020197019625A patent/KR20200018383A/en not_active Application Discontinuation
-
2019
- 2019-06-02 IL IL267023A patent/IL267023A/en unknown
Non-Patent Citations (1)
Title |
---|
MIRKIN SEBASTIAN ET AL: "17ß-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review", HORMONAL INFLUENCES IN MULTIPLE SCLEROSIS: NEW THERAPEUTIC BENEFITS FOR STEROIDS,, vol. 81, no. 1, 30 April 2015 (2015-04-30), pages 28 - 35, XP009520141, ISSN: 1873-4111, DOI: 10.1016/J.MATURITAS.2015.02.266 * |
Also Published As
Publication number | Publication date |
---|---|
RU2019115913A (en) | 2021-01-15 |
CA3045024A1 (en) | 2018-07-26 |
RU2019115913A3 (en) | 2021-03-19 |
MX2019006513A (en) | 2019-08-14 |
BR112019011655A2 (en) | 2019-10-22 |
JP2020504093A (en) | 2020-02-06 |
WO2018136161A9 (en) | 2019-08-22 |
WO2018136161A1 (en) | 2018-07-26 |
IL267023A (en) | 2019-07-31 |
EP3548036A1 (en) | 2019-10-09 |
KR20200018383A (en) | 2020-02-19 |
AU2017394679A1 (en) | 2019-06-13 |
CN110290793A (en) | 2019-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL248985A0 (en) | Natural combination hormone replacement formulations and therapies | |
IL273510A (en) | Combination therapies and uses thereof | |
EP3328377A4 (en) | Compositions and methods for immuno-oncology therapies | |
EP3585433A4 (en) | Therapeutic compositions and related methods for photoimmunotherapy | |
EP3355954A4 (en) | Delivery methods and compositions | |
EP3463248A4 (en) | Devices and methods for using medicament devices | |
EP3508095A4 (en) | Chair structure and chair | |
EP3585195A4 (en) | Respirators and related methods | |
EP3310376A4 (en) | Modified therapeutic agents and compositions thereof | |
EP3615029A4 (en) | Formulations for extending lifespan and healthspan | |
EP3368546A4 (en) | Sstr-targeted conjugates and particles and formulations thereof | |
EP3134061A4 (en) | Peroxide formulations and methods and applicators for using the same | |
EP3548047A4 (en) | Steroid administration and immunotherapy | |
EP3534910A4 (en) | Therapeutic agents and methods | |
EP3118305A4 (en) | Recombinant microorganism expressing avermectin analogue and use thereof | |
EP3516993A4 (en) | Chair and chair structure | |
EP3177286A4 (en) | Compositions and methods for physiological delivery using cannabidiol | |
EP3191114A4 (en) | Occidiofungin formulations and uses thereof | |
EP3630135A4 (en) | Compositions and methods for providing cell replacement therapy | |
EP3638205A4 (en) | Devices and methods for delivering therapeutics | |
EP3094323A4 (en) | Methods and compositions for modulating hormone levels | |
EP3348206A4 (en) | Therapeutic substance delivery device and therapeutic substance delivery kit | |
EP3302267A4 (en) | Resuscitation and ventilation monitor | |
EP3684789A4 (en) | Zein-enriched and depleted protein | |
EP3515417A4 (en) | Delivery devices and methods for making the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190529 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200514 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/57 20060101ALI20200508BHEP Ipc: A61K 31/565 20060101AFI20200508BHEP Ipc: A61K 47/44 20170101ALI20200508BHEP Ipc: A61P 5/30 20060101ALI20200508BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40034648 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230526 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20231006 |